Immunohistochemical analysis for p53 revealed that the mutant-specific shRNA-expressing tumors had significantly reduced p53, indicating that the specific shRNAs are effective in silencing the expression of the respective mutant p53 in vivo during tumor growth (Fig. 7b). The gene discussed is TP53; the disease is neoplasm.